More specifically, we detected 16 different HLA-A, 24 different HLA-B, 14 different HLA-C, seven different HLA-DQB1, and 13 different HLA-DRB1 molecules in patients with DLBCL and control subjects (Supplementary Table S1). Here, HLA-C is linked to diffuse large B-cell lymphoma.